Synthesis and cytotoxicity of 2,5-dihydroxychalcones and related compounds

Archives of Pharmacal Research

Volumn 27, Issue 6, 2004, Pages 581-588

  Nam, Nguyen Hai ^a   Hong, Dong Ho ^a   You, Young Jae ^a   Kim, Yong ^a   Bang, Seong Cheol ^a   Kim, Hwan Mook ^b   Ahn, Byung Zun ^a  

^a Chungnam National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Chalcone; Cytotoxicity; Structure activity relationship

Indexed keywords

2',5' DIHYDROXYCHALCONE; 2',5'-DIHYDROXYCHALCONE; ANTINEOPLASTIC AGENT; CHALCONE; CHALCONE DERIVATIVE; DRUG DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; MOUSE; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL LINE; UMBILICAL VEIN;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHALCONE; CHALCONES; ENDOTHELIAL CELLS; HUMANS; MICE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; UMBILICAL VEINS;

EID: 21644442255     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02980153     Document Type: Article

References (12)

1. Ahn, B. Z. and Sok, D. E., Michael acceptor as a tool for anticancer drugs design. Curr. Pharm. Design, 2, 247-262 (1996).
2. Edwards, M. L., Stemerick, D. M., and Sunkara, P. S., Chalcones: A new class of antimitotic agents. J. Med. Chem., 33, 1948-1954 (1990).
3. Folkman, J., Tumor angiogenesis: therapeutic applications. N. Engl. J. Med., 285, 1182-1186 (1971).
4. Gastl, G., Hermann, T., Steurer, M., Zmijia, J., Gunsilius, E., Unger, C., and Kraft, A., Angiogenesis as a target for tumor treatment. Oncology 54, 177-184 (1997).
5. Gazit, A., Osherov, N., Posner, I., Yaish, P., Poradosu, E., Gilon, C., and Levitzki, A., Tyrphostins. 2. Heterocyclic and α-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. J. Med. Chem., 34, 1896-1907 (1991).
6. Kolibaba,, K. S. and Druker, B. J., Protein tyrosine kinases and cancer. Biochim. Biophys. Acta, 1333, 217-248 (1997).
7. Lee, K. H., Huang, E. S., Piantadosi, C., Pagano, J., and Geissman, T. A., Cytotoxicity of sesquiterpene lactones. Cancer Res., 31, 1649-1654 (1971).
8. Lee, K. H., Hall, I. H., Starness, C. D., Elgebaly, S. A., Waddell, T. G., Hadgraft, R. T., Ruffler, C. G., and Weidner, I., Sesquiterpene antitumor agents: inhibitors of cellular metabolism. Science, 196, 533-536 (1977).
9. Nam, N. H., Huong, H. T. T., Kim, H. M., and Ahn, B. Z., Cytotoxic constituents from Notopterygium incisum. Kor. J. Pharmacogn., 31, 77-81 (2000)..
10. Nam, N. H., You, Y. J., Kim, Y., Hong, D. H., Kim, H. M., and Ahn, B. Z., Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity. Bioorg. Med. Chem. Lett., 11, 1173-1176 (2001).
11. Ollinger, K., Llopis, J., and Cadenas, E., Study of the redox properties of naphthazarin (5,8-dihydroxy-1,4-naphthoquinone) and its glutathionyl conjugate in biological reactions: one-and two-electron enzymatic reduction. Arch. Biochem. Biophys., 275, 514-530 (1989).
12. Pratt, W. B., Ruddon, R. W., Ensminger, W. D., and Maybaum, J., The anticancer drugs. Oxford University Press, Oxford, pp. 183-198, (1994).